STC2 is the target gene of HIF-1 and has been proved to be a prognostic marker of ovarian cancer, breast cancer, and kidney cancer (Chang et al., 2003; Buckanovich et al., 2007; Esseghir et al., 2007). The gene discussed is STC2; the disease is breast carcinoma.